Total Payments
$17,278
2024 Payments
$4,538
Companies
26
Transactions
247
Medicare Patients
7,095
Medicare Billing
$494,787
Payment Breakdown by Category
Other$9,023 (52.2%)
Food & Beverage$5,857 (33.9%)
Consulting$2,258 (13.1%)
Education$140.59 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,023 | 1 | 52.2% |
| Food and Beverage | $5,857 | 239 | 33.9% |
| Consulting Fee | $2,258 | 1 | 13.1% |
| Education | $140.59 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $9,062 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $2,712 | 22 | $0 (2024) |
| ABBVIE INC. | $1,489 | 99 | $0 (2024) |
| Amgen Inc. | $478.21 | 6 | $0 (2024) |
| Dermavant Sciences, Inc. | $443.04 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $370.13 | 12 | $0 (2024) |
| Organogenesis Inc. | $315.43 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $311.84 | 16 | $0 (2024) |
| LEO Pharma Inc. | $283.05 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $266.75 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,538 | 81 | E.R. Squibb & Sons, L.L.C. ($2,606) |
| 2023 | $1,171 | 56 | AbbVie Inc. ($348.68) |
| 2022 | $1,201 | 55 | ABBVIE INC. ($446.30) |
| 2021 | $348.34 | 17 | AbbVie Inc. ($148.57) |
| 2020 | $476.09 | 29 | AbbVie Inc. ($192.81) |
| 2019 | $125.65 | 4 | Ortho Dermatologics, a division of Bausch Health US, LLC ($77.34) |
| 2018 | $121.28 | 1 | Allergan Inc. ($121.28) |
| 2017 | $9,296 | 4 | Incyte Corporation ($9,023) |
All Payment Transactions
247 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Organogenesis Inc. | APLIGRAF (Device) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: WOUND CARE | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.30 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.92 | General |
| Category: Immunology | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.88 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Organogenesis Inc. | CYGNUS DUAL (Medical Supply) | Food and Beverage | In-kind items and services | $50.12 | General |
| Category: WOUND CARE | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.59 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.02 | General |
| Category: Immunology | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.34 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $123.08 | General |
| Category: Inflammation | ||||||
| 10/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $84.96 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: DERMATOLOGY | ||||||
| 10/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.37 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,616 | 3,085 | $355,628 | $114,404 |
| 2022 | 15 | 1,372 | 2,911 | $314,686 | $101,542 |
| 2021 | 16 | 1,991 | 3,614 | $444,971 | $146,340 |
| 2020 | 15 | 2,116 | 3,396 | $407,836 | $132,501 |
Total Patients
7,095
Total Services
13,006
Medicare Billing
$494,787
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 282 | $70,862 | $23,458 | 33.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 204 | 252 | $56,033 | $18,933 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 301 | $53,438 | $17,228 | 32.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 251 | 333 | $43,915 | $11,026 | 25.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 161 | 186 | $36,934 | $10,793 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $23,771 | $8,743 | 36.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 197 | 1,199 | $15,687 | $5,965 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $17,839 | $5,520 | 30.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 24 | 32 | $10,637 | $3,880 | 36.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 19 | $6,697 | $2,348 | 35.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 52 | $5,097 | $1,944 | 38.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 30 | $3,294 | $1,075 | 32.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,695 | $1,056 | 39.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 21 | 21 | $2,922 | $874.22 | 29.9% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 18 | $3,428 | $790.31 | 23.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 13 | $1,459 | $439.25 | 30.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 21 | $580.36 | $207.43 | 35.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 160 | $338.81 | $123.69 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 233 | $59,489 | $20,676 | 34.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 169 | 215 | $48,754 | $17,045 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 248 | $44,778 | $14,605 | 32.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 225 | 310 | $41,798 | $10,606 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 76 | 76 | $24,891 | $7,743 | 31.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 120 | 128 | $26,518 | $7,353 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 99 | 99 | $21,610 | $6,738 | 31.2% |
About Dr. Karl Staser, MD
Dr. Karl Staser, MD is a Dermatology healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1992144174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karl Staser, MD has received a total of $17,278 in payments from pharmaceutical and medical device companies, with $4,538 received in 2024. These payments were reported across 247 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,023).
As a Medicare-enrolled provider, Staser has provided services to 7,095 Medicare beneficiaries, totaling 13,006 services with total Medicare billing of $494,787. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Evansville, IN
- Active Since 06/20/2013
- Last Updated 09/01/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1992144174
Products in Payments
- JAKAFI (Drug) $9,023
- SKYRIZI (Biological) $978.69
- DUPIXENT (Biological) $451.31
- VTAMA (Drug) $443.04
- Otezla (Drug) $393.76
- RINVOQ (Biological) $328.68
- TREMFYA (Drug) $266.75
- Sotyktu (Drug) $262.72
- ADBRY (Biological) $250.74
- SPEVIGO (Drug) $231.77
- TALTZ (Drug) $231.50
- LIBTAYO (Biological) $181.06
- HUMIRA (Biological) $173.28
- COSENTYX (Drug) $149.50
- COSENTYX (Biological) $137.75
- Kerecis Omega3 SurgiClose (Device) $126.07
- JUBLIA (Drug) $89.00
- Ilumya (Biological) $87.34
- Enbrel (Biological) $84.45
- EUCRISA (Drug) $73.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Evansville
Dr. Charles Hudson, M.d, M.D
Dermatology — Payments: $255,404
Dermatology $255,404
Dr. Celine Mestel, M.d, Phd, M.D, PHD
Dermatology — Payments: $11,824
Dermatology $11,824
Jamie Mull, Md, MD
Dermatology — Payments: $9,501
Dermatology $9,501
Jon Davis, Md, MD
Dermatology — Payments: $9,309
Dermatology $9,309
Kirk Ashburn, A.r.n.p, A.R.N.P
Dermatology — Payments: $8,833
Dermatology $8,833
Joseph Tadros, Md, MD
Dermatology — Payments: $4,228
Dermatology $4,228